- Home
- Publications
- Publication Search
- Publication Details
Title
Echinocandin Resistance in Candida
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 61, Issue suppl_6, Pages S612-S617
Publisher
Oxford University Press (OUP)
Online
2015-11-13
DOI
10.1093/cid/civ791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
- (2014) Cau D. Pham et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole
- (2014) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systemic Antifungal Prophylaxis After Hematopoietic Stem Cell Transplantation: A Meta-Analysis
- (2014) Panayiotis D. Ziakas et al. CLINICAL THERAPEUTICS
- The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods
- (2014) Ronen Ben-Ami et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
- (2014) Maiken C. Arendrup et al. DRUG RESISTANCE UPDATES
- Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
- (2014) David S. Perlin DRUGS
- Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
- (2014) A. Fekkar et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Candida glabrata Intra-Abdominal Candidiasis Is Characterized by Persistence within the Peritoneal Cavity and Abscesses
- (2014) Shaoji Cheng et al. INFECTION AND IMMUNITY
- Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria
- (2014) Michael A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Development of echinocandin-resistantCandida albicanscandidemia following brief prophylactic exposure to micafungin therapy
- (2014) M.A. Ruggero et al. Transplant Infectious Disease
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Matrix β-1,3 Glucan in Antifungal Resistance of Non-albicans Candida Biofilms
- (2013) K. F. Mitchell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method
- (2013) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
- (2013) James S. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin
- (2013) A. Fekkar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade
- (2013) A. M. Tortorano et al. INFECTION
- Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance
- (2012) Santosh K. Katiyar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- Micafungin
- (2012) Lesley J. Scott DRUGS
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
- (2012) Sheena D. Singh-Babak et al. PLoS Pathogens
- Candida glabrataMutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
- (2011) Kelley R. Healey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
- (2011) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
- (2011) J. L. Slater et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Fks Hot Spot for Acquired Echinocandin Resistance inSaccharomyces cerevisiaeand Its Contribution to Intrinsic Resistance ofScedosporiumSpecies
- (2011) Michael E. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin ResistanceIn Vivo
- (2011) Keunsook K. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on anidulafungin
- (2011) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Current perspectives on echinocandin class drugs
- (2011) David S Perlin Future Microbiology
- Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy
- (2011) Susan J. Howard et al. JOURNAL OF INFECTIOUS DISEASES
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- Importance of Candida–bacterial polymicrobial biofilms in disease
- (2011) Melphine M. Harriott et al. TRENDS IN MICROBIOLOGY
- Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
- (2010) M. Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
- (2010) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Epidemiology of Candida Colonization and Invasive Candidiasis in a Surgical Intensive Care Unit Where Fluconazole Prophylaxis is Utilized
- (2009) Shelley S. Magill et al. ANNALS OF SURGERY
- Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae
- (2009) S. K. Katiyar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins andCandidaspp.
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Candida colonisation as a source for candidaemia
- (2009) L.N. Miranda et al. JOURNAL OF HOSPITAL INFECTION
- Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
- (2009) Sheena D. Singh et al. PLoS Pathogens
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity
- (2008) Armêl Plaine et al. FUNGAL GENETICS AND BIOLOGY
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Caspofungin Modulates Inflammatory Responses toAspergillus fumigatusthrough Stage‐Specific Effects on Fungal β‐Glucan Exposure
- (2008) T. M. Hohl et al. JOURNAL OF INFECTIOUS DISEASES
- Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination
- (2008) Andrew Y. Koh et al. PLoS Pathogens
- Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
- (2008) Louise A. Walker et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started